An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries.
Body, Jean-Jacques
An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries. [electronic resource] - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 09 2017 - 2823-2832 p. digital
Publication Type: Journal Article; Multicenter Study
1433-7339
10.1007/s00520-017-3697-5 doi
Bone Density Conservation Agents--administration & dosage
Bone Neoplasms--drug therapy
Denosumab--administration & dosage
Diphosphonates--administration & dosage
Europe
Female
Humans
Imidazoles--administration & dosage
Infusions, Intravenous
Injections, Subcutaneous
Male
Time and Motion Studies
Zoledronic Acid
An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries. [electronic resource] - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 09 2017 - 2823-2832 p. digital
Publication Type: Journal Article; Multicenter Study
1433-7339
10.1007/s00520-017-3697-5 doi
Bone Density Conservation Agents--administration & dosage
Bone Neoplasms--drug therapy
Denosumab--administration & dosage
Diphosphonates--administration & dosage
Europe
Female
Humans
Imidazoles--administration & dosage
Infusions, Intravenous
Injections, Subcutaneous
Male
Time and Motion Studies
Zoledronic Acid